TreeWAS – Variant ID: rs8005161

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K50 Crohn's disease [regional enteritis]	0.990	0.010	0.000
K50.9 Crohn's disease, unspecified	0.989	0.011	0.000
K50.0 Crohn's disease of small intestine	0.986	0.014	0.000
K50.1 Crohn's disease of large intestine	0.975	0.025	0.000
K50.8 Other Crohn's disease	0.832	0.167	0.000
K50-K52 Noninfective enteritis and colitis	0.304	0.696	0.000
K51 Ulcerative colitis	0.254	0.746	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.234	0.766	0.000
K51.8 Other ulcerative colitis	0.208	0.792	0.000
K51.4 Pseudopolyposis of colon	0.193	0.807	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.192	0.808	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.182	0.817	0.000
K51.2 Ulcerative (chronic) proctitis	0.168	0.832	0.000
K51.5 Mucosal proctocolitis	0.160	0.840	0.000
K51.9 Ulcerative colitis, unspecified	0.087	0.913	0.000
K52 Other non-infective gastro-enteritis and colitis	0.061	0.939	0.000
K52.3 Indeterminate colitis	0.050	0.950	0.000
I12.0 Hypertensive renal disease with renal failure	0.047	0.953	0.000
K52.2 Allergic and dietetic gastro-enteritis and colitis	0.044	0.956	0.000
K52.1 Toxic gastro-enteritis and colitis	0.039	0.960	0.000
I12 Hypertensive renal disease	0.037	0.963	0.000
K52.0 Gastro-enteritis and colitis due to radiation	0.036	0.964	0.000
I10-I15 Hypertensive diseases	0.030	0.970	0.000
I10 Essential (primary) hypertension	0.028	0.972	0.000
I12.9 Hypertensive renal disease without renal failure	0.028	0.972	0.000
I15 Secondary hypertension	0.023	0.977	0.000
I11 Hypertensive heart disease	0.022	0.978	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.022	0.978	0.000
I13 Hypertensive heart and renal disease	0.021	0.979	0.000
I15.1 Hypertension secondary to other renal disorders	0.018	0.982	0.000
N28.8 Other specified disorders of kidney and ureter	0.017	0.983	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.017	0.983	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.016	0.983	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.017	0.983	0.000
I15.9 Seconday hypertension, unspecified	0.016	0.984	0.000
I15.8 Other secondary hypertension	0.016	0.984	0.000
I15.2 Hypertension secondary to endocrine disorders	0.016	0.984	0.000
I15.0 Renovascular hypertension	0.016	0.984	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.016	0.984	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.015	0.984	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.015	0.984	0.000
I13.1 Hypertensive heart and renal disease with renal failure	0.015	0.984	0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.015	0.984	0.000
N28 Other disorders of kidney and ureter, not elsewhere classified	0.014	0.986	0.000
M06.9 Rheumatoid arthritis, unspecified	0.013	0.987	0.000
N28.0 Ischaemia and infarction of kidney	0.013	0.987	0.000
N28.9 Disorder of kidney and ureter, unspecified	0.012	0.988	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.012	0.988	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.012	0.988	0.000
N28.1 Cyst of kidney, acquired	0.011	0.989	0.000
F11.1 Harmful use	0.011	0.989	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.011	0.989	0.000
F11 Mental and behavioural disorders due to use of opioids	0.011	0.989	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.010	0.990	0.000
E04.9 Non-toxic goitre, unspecified	0.010	0.990	0.000
F11.2 Dependence syndrome	0.010	0.990	0.000
C43.5 Malignant melanoma of trunk	0.010	0.990	0.000
C43 Malignant melanoma of skin	0.010	0.990	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.010	0.990	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.010	0.990	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.010	0.990	0.000
C43.9 Malignant melanoma of skin, unspecified	0.010	0.990	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.009	0.991	0.000
F11.3 Withdrawal state	0.009	0.991	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.009	0.991	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.009	0.991	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.009	0.991	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.008	0.992	0.000
F10.4 Withdrawal state with delirium	0.008	0.992	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.008	0.992	0.000
F11.9 Unspecified mental and behavioural disorder	0.008	0.992	0.000
F11.8 Other mental and behavioural disorders	0.008	0.992	0.000
F11.7 Residual and late-onset psychotic disorder	0.008	0.992	0.000
F11.6 Amnesic syndrome	0.008	0.992	0.000
F11.5 Psychotic disorder	0.008	0.992	0.000
F11.4 Withdrawal state with delirium	0.008	0.992	0.000
F11.0 Acute intoxication	0.008	0.992	0.000
F10.0 Acute intoxication	0.008	0.992	0.000
E04.1 Non-toxic single thyroid nodule	0.008	0.992	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.008	0.992	0.000
R25.1 Tremor, unspecified	0.008	0.992	0.000
E04 Other non-toxic goitre	0.008	0.992	0.000
C43.4 Malignant melanoma of scalp and neck	0.008	0.992	0.000
C43.8 Overlapping malignant melanoma of skin	0.008	0.992	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.008	0.992	0.000
C43.0 Malignant melanoma of lip	0.008	0.992	0.000
F10.1 Harmful use	0.008	0.992	0.000
F12.2 Dependence syndrome	0.007	0.993	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.007	0.993	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.007	0.993	0.000
G55.2 Nerve root and plexus compressions in spondylosis	0.000	0.993	0.007
F10.6 Amnesic syndrome	0.007	0.993	0.000
F10.2 Dependence syndrome	0.007	0.993	0.000
K65.0 Acute peritonitis	0.007	0.993	0.000
F12.1 Harmful use	0.007	0.993	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.007	0.993	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.007	0.993	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.007	0.993	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.007	0.993	0.000
F10.8 Other mental and behavioural disorders	0.007	0.993	0.000
F10.7 Residual and late-onset psychotic disorder	0.007	0.993	0.000
M06 Other rheumatoid arthritis	0.007	0.993	0.000
F10.5 Psychotic disorder	0.006	0.993	0.000
K65 Peritonitis	0.007	0.993	0.000
K65.8 Other peritonitis	0.006	0.994	0.000
Z13.6 Special screening examination for cardiovascular disorders	0.006	0.994	0.000
F12.9 Unspecified mental and behavioural disorder	0.006	0.994	0.000
F12.8 Other mental and behavioural disorders	0.006	0.994	0.000
F12.7 Residual and late-onset psychotic disorder	0.006	0.994	0.000
F12.6 Amnesic syndrome	0.006	0.994	0.000
F12.5 Psychotic disorder	0.006	0.994	0.000
F12.4 Withdrawal state with delirium	0.006	0.994	0.000
F12.3 Withdrawal state	0.006	0.994	0.000
F12.0 Acute intoxication	0.006	0.994	0.000
F15.1 Harmful use	0.006	0.994	0.000
F19.1 Harmful use	0.006	0.994	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.006	0.994	0.000
N02.9 Unspecified	0.006	0.994	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.006	0.994	0.000
K65.9 Peritonitis, unspecified	0.006	0.994	0.000
E04.0 Non-toxic diffuse goitre	0.006	0.994	0.000
F10.9 Unspecified mental and behavioural disorder	0.006	0.994	0.000
E04.8 Other specified non-toxic goitre	0.006	0.994	0.000
R25.8 Other and unspecified abnormal involuntary movements	0.006	0.994	0.000
R25 Abnormal involuntary movements	0.006	0.994	0.000
E14.9 Without complications	0.006	0.994	0.000
F15.9 Unspecified mental and behavioural disorder	0.005	0.994	0.000
F15.8 Other mental and behavioural disorders	0.005	0.994	0.000
F15.7 Residual and late-onset psychotic disorder	0.005	0.994	0.000
F15.6 Amnesic syndrome	0.005	0.994	0.000
F15.5 Psychotic disorder	0.005	0.994	0.000
F15.4 Withdrawal state with delirium	0.005	0.994	0.000
F15.3 Withdrawal state	0.005	0.994	0.000
F15.2 Dependence syndrome	0.005	0.994	0.000
F15.0 Acute intoxication	0.005	0.994	0.000
F19.9 Unspecified mental and behavioural disorder	0.005	0.994	0.000
F19.8 Other mental and behavioural disorders	0.005	0.994	0.000
F19.7 Residual and late-onset psychotic disorder	0.005	0.994	0.000
F19.6 Amnesic syndrome	0.005	0.994	0.000
F19.5 Psychotic disorder	0.005	0.994	0.000
F19.4 Withdrawal state with delirium	0.005	0.994	0.000
F19.3 Withdrawal state	0.005	0.994	0.000
F19.2 Dependence syndrome	0.005	0.994	0.000
F19.0 Acute intoxication	0.005	0.994	0.000
M06.3 Rheumatoid nodule	0.005	0.995	0.000
M06.4 Inflammatory polyarthropathy	0.005	0.995	0.000
K61.0 Anal abscess	0.005	0.995	0.000
E14 Unspecified diabetes mellitus	0.005	0.995	0.000
F13.9 Unspecified mental and behavioural disorder	0.005	0.995	0.000
F13.8 Other mental and behavioural disorders	0.005	0.995	0.000
F13.7 Residual and late-onset psychotic disorder	0.005	0.995	0.000
F13.6 Amnesic syndrome	0.005	0.995	0.000
F13.5 Psychotic disorder	0.005	0.995	0.000
F13.4 Withdrawal state with delirium	0.005	0.995	0.000
F13.3 Withdrawal state	0.005	0.995	0.000
F13.2 Dependence syndrome	0.005	0.995	0.000
F13.1 Harmful use	0.005	0.995	0.000
F13.0 Acute intoxication	0.005	0.995	0.000
F14.9 Unspecified mental and behavioural disorder	0.005	0.995	0.000
F14.8 Other mental and behavioural disorders	0.005	0.995	0.000
F14.7 Residual and late-onset psychotic disorder	0.005	0.995	0.000
F14.6 Amnesic syndrome	0.005	0.995	0.000
F14.5 Psychotic disorder	0.005	0.995	0.000
F14.4 Withdrawal state with delirium	0.005	0.995	0.000
F14.3 Withdrawal state	0.005	0.995	0.000
F14.2 Dependence syndrome	0.005	0.995	0.000
F14.1 Harmful use	0.005	0.995	0.000
F14.0 Acute intoxication	0.005	0.995	0.000
F16.9 Unspecified mental and behavioural disorder	0.005	0.995	0.000
F16.8 Other mental and behavioural disorders	0.005	0.995	0.000
F16.7 Residual and late-onset psychotic disorder	0.005	0.995	0.000
F16.6 Amnesic syndrome	0.005	0.995	0.000
F16.5 Psychotic disorder	0.005	0.995	0.000
F16.4 Withdrawal state with delirium	0.005	0.995	0.000
F16.3 Withdrawal state	0.005	0.995	0.000
F16.2 Dependence syndrome	0.005	0.995	0.000
F16.1 Harmful use	0.005	0.995	0.000
F16.0 Acute intoxication	0.005	0.995	0.000
F18.9 Unspecified mental and behavioural disorder	0.005	0.995	0.000
F18.8 Other mental and behavioural disorders	0.005	0.995	0.000
F18.7 Residual and late-onset psychotic disorder	0.005	0.995	0.000
F18.6 Amnesic syndrome	0.005	0.995	0.000
F18.5 Psychotic disorder	0.005	0.995	0.000
F18.4 Withdrawal state with delirium	0.005	0.995	0.000
F18.3 Withdrawal state	0.005	0.995	0.000
F18.2 Dependence syndrome	0.005	0.995	0.000
F18.1 Harmful use	0.005	0.995	0.000
F18.0 Acute intoxication	0.005	0.995	0.000
M06.8 Other specified rheumatoid arthritis	0.005	0.995	0.000
M06.2 Rheumatoid bursitis	0.005	0.995	0.000
M06.1 Adult-onset Still's disease	0.005	0.995	0.000
Z96.6 Presence of orthopaedic joint implants	0.005	0.995	0.000
E14.4 With neurological complications	0.005	0.995	0.000
R25.3 Fasciculation	0.005	0.995	0.000
M06.0 Seronegative rheumatoid arthritis	0.005	0.995	0.000
K82.8 Other specified diseases of gallbladder	0.000	0.995	0.005
E04.2 Non-toxic multinodular goitre	0.005	0.995	0.000
N25-N29 Other disorders of kidney and ureter	0.005	0.995	0.000
E14.1 With ketoacidosis	0.005	0.995	0.000
F10.3 Withdrawal state	0.005	0.995	0.000
N02 Recurrent and persistent haematuria	0.005	0.995	0.000
X63.0 Home	0.005	0.995	0.000
M06.34 Rheumatoid nodule (Hand)	0.004	0.996	0.000
K08.3 Retained dental root	0.004	0.996	0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.004	0.996	0.000
N04 Nephrotic syndrome	0.004	0.996	0.000
X62.9 Unspecified place	0.004	0.996	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.004	0.996	0.000
M06.32 Rheumatoid nodule (Upper arm)	0.004	0.996	0.000
N04.9 Unspecified	0.004	0.996	0.000
R25.0 Abnormal head movements	0.004	0.996	0.000
M06.37 Rheumatoid nodule (Ankle and foot)	0.004	0.996	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.004	0.996	0.000
M06.39 Rheumatoid nodule (Site unspecified)	0.004	0.996	0.000
M06.38 Rheumatoid nodule (Other)	0.004	0.996	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.004	0.996	0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.004	0.996	0.000
M06.33 Rheumatoid nodule (Forearm)	0.004	0.996	0.000
M06.31 Rheumatoid nodule (Shoulder region)	0.004	0.996	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.004	0.996	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.004	0.996	0.000
N00-N08 Glomerular diseases	0.004	0.996	0.000
M06.48 Inflammatory polyarthropathy (Other)	0.004	0.996	0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.004	0.996	0.000
M06.46 Inflammatory polyarthropathy (Lower leg)	0.004	0.996	0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.004	0.996	0.000
M06.44 Inflammatory polyarthropathy (Hand)	0.004	0.996	0.000
M06.43 Inflammatory polyarthropathy (Forearm)	0.004	0.996	0.000
M06.42 Inflammatory polyarthropathy (Upper arm)	0.004	0.996	0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.004	0.996	0.000
X60-X84 Intentional self-harm	0.004	0.996	0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.004	0.996	0.000
E14.8 With unspecified complications	0.004	0.996	0.000
E14.7 With multiple complications	0.004	0.996	0.000
E14.6 With other specified complications	0.004	0.996	0.000
E14.5 With peripheral circulatory complications	0.004	0.996	0.000
E14.2 Withrenal complications	0.004	0.996	0.000
E14.0 With coma	0.004	0.996	0.000
E14.3 With ophthalmic complications	0.004	0.996	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.004	0.996	0.000
M06.18 Adult-onset Still's disease (Other)	0.004	0.996	0.000
M06.17 Adult-onset Still's disease (Ankle and foot)	0.004	0.996	0.000
M06.16 Adult-onset Still's disease (Lower leg)	0.004	0.996	0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.004	0.996	0.000
M06.14 Adult-onset Still's disease (Hand)	0.004	0.996	0.000
M06.13 Adult-onset Still's disease (Forearm)	0.004	0.996	0.000
M06.12 Adult-onset Still's disease (Upper arm)	0.004	0.996	0.000
M06.11 Adult-onset Still's disease (Shoulder region)	0.004	0.996	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.004	0.996	0.000
M06.29 Rheumatoid bursitis (Site unspecified)	0.004	0.996	0.000
M06.28 Rheumatoid bursitis (Other)	0.004	0.996	0.000
M06.27 Rheumatoid bursitis (Ankle and foot)	0.004	0.996	0.000
M06.26 Rheumatoid bursitis (Lower leg)	0.004	0.996	0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.004	0.996	0.000
M06.24 Rheumatoid bursitis (Hand)	0.004	0.996	0.000
M06.23 Rheumatoid bursitis (Forearm)	0.004	0.996	0.000
M06.22 Rheumatoid bursitis (Upper arm)	0.004	0.996	0.000
M06.21 Rheumatoid bursitis (Shoulder region)	0.004	0.996	0.000
M06.20 Rheumatoid bursitis (Multiple sites)	0.004	0.996	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.004	0.996	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.004	0.996	0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.004	0.996	0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.004	0.996	0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.004	0.996	0.000
M06.84 Other specified rheumatoid arthritis (Hand)	0.004	0.996	0.000
M06.83 Other specified rheumatoid arthritis (Forearm)	0.004	0.996	0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.004	0.996	0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.004	0.996	0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.004	0.996	0.000
N04.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.004	0.996	0.000
K82.4 Cholesterolosis of gallbladder	0.000	0.996	0.004
N08.5 Glomerular disorders in systemic connective tissue disorders	0.004	0.996	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.003	0.996	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.003	0.996	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.003	0.996	0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.003	0.996	0.000
M06.04 Seronegative rheumatoid arthritis (Hand)	0.003	0.996	0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.003	0.996	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.003	0.996	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.003	0.996	0.000
N27 Small kidney of unknown cause	0.004	0.996	0.000
X78 Intentional self-harm by sharp object	0.004	0.996	0.000
K82 Other diseases of gallbladder	0.000	0.996	0.004
N29 Other disorders of kidney and ureter in diseases classified elsewhere	0.003	0.996	0.000
E10-E14 Diabetes mellitus	0.004	0.996	0.000
N05 Unspecified nephritic syndrome	0.004	0.996	0.000
E10 Insulin-dependent diabetes mellitus	0.004	0.996	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.003	0.996	0.000
N02.6 Dense deposit disease	0.003	0.996	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.996	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.996	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.996	0.000
N02.2 Diffuse membranous glomerulonephritis	0.003	0.996	0.000
N02.1 Focal and segmental glomerular lesions	0.003	0.996	0.000
N02.0 Minor glomerular abnormality	0.003	0.996	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.003	0.996	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.003	0.996	0.000
E10.5 With peripheral circulatory complications	0.003	0.996	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.003	0.997	0.000
X78.0 Home	0.003	0.997	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.003	0.997	0.000
N25 Disorders resulting from impaired renal tubular function	0.003	0.997	0.000
N04.8 Other	0.003	0.997	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N04.6 Dense deposit disease	0.003	0.997	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N04.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
N04.0 Minor glomerular abnormality	0.003	0.997	0.000
E10.1 With ketoacidosis	0.003	0.997	0.000
X63.9 Unspecified place	0.003	0.997	0.000
X63.8 Other specified place	0.003	0.997	0.000
X63.7 Farm	0.003	0.997	0.000
X63.6 Industrial and construction area	0.003	0.997	0.000
X63.5 Trade and service area	0.003	0.997	0.000
X63.4 Street and highway	0.003	0.997	0.000
X63.3 Sports and athletics area	0.003	0.997	0.000
X63.2 School, other institution and public administrative area	0.003	0.997	0.000
X63.1 Residential institution	0.003	0.997	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.003	0.997	0.000
X62.0 Home	0.003	0.997	0.000
X62.8 Other specified place	0.003	0.997	0.000
X62.7 Farm	0.003	0.997	0.000
X62.6 Industrial and construction area	0.003	0.997	0.000
X62.5 Trade and service area	0.003	0.997	0.000
X62.4 Street and highway	0.003	0.997	0.000
X62.3 Sports and athletics area	0.003	0.997	0.000
X62.2 School, other institution and public administrative area	0.003	0.997	0.000
X62.1 Residential institution	0.003	0.997	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.003	0.997	0.000
N06 Isolated proteinuria with specified morphological lesion	0.003	0.997	0.000
N01 Rapidly progressive nephritic syndrome	0.003	0.997	0.000
N00 Acute nephritic syndrome	0.003	0.997	0.000
K82.1 Hydrops of gallbladder	0.000	0.997	0.003
X84 Intentional self-harm by unspecified means	0.003	0.997	0.000
X83 Intentional self-harm by other specified means	0.003	0.997	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.003	0.997	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.003	0.997	0.000
X80 Intentional self-harm by jumping from a high place	0.003	0.997	0.000
X79 Intentional self-harm by blunt object	0.003	0.997	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.003	0.997	0.000
X76 Intentional self-harm by smoke, fire and flames	0.003	0.997	0.000
X75 Intentional self-harm by explosive material	0.003	0.997	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.003	0.997	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.003	0.997	0.000
X72 Intentional self-harm by handgun discharge	0.003	0.997	0.000
X71 Intentional self-harm by drowning and submersion	0.003	0.997	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.003	0.997	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.003	0.997	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.003	0.997	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
N05.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
X69.0 Home	0.003	0.997	0.000
E13 Other specified diabetes mellitus	0.003	0.997	0.000
K82.9 Disease of gallbladder, unspecified	0.000	0.997	0.003
X68.9 Unspecified place	0.003	0.997	0.000
S83.2 Tear of meniscus, current	0.000	0.997	0.003
N03 Chronic nephritic syndrome	0.003	0.997	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.003	0.997	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.003	0.997	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.003	0.997	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.003	0.997	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
N27.0 Small kidney, unilateral	0.003	0.997	0.000
N26 Unspecified contracted kidney	0.003	0.997	0.000
K26.7 Chronic without haemorrhage or perforation	0.003	0.997	0.000
N05.8 Other	0.003	0.997	0.000
S81.9 Open wound of lower leg, part unspecified	0.003	0.997	0.000
K82.2 Perforation of gallbladder	0.000	0.997	0.003
N27.9 Small kidney, unspecified	0.003	0.997	0.000
N27.1 Small kidney, bilateral	0.003	0.997	0.000
X67.9 Unspecified place	0.003	0.997	0.000
N18.5 Chronic kidney disease, stage 5	0.003	0.997	0.000
X78.9 Unspecified place	0.003	0.997	0.000
X78.8 Other specified place	0.003	0.997	0.000
X78.7 Farm	0.003	0.997	0.000
X78.6 Industrial and construction area	0.003	0.997	0.000
X78.5 Trade and service area	0.003	0.997	0.000
X78.4 Street and highway	0.003	0.997	0.000
X78.3 Sports and athletics area	0.003	0.997	0.000
X78.2 School, other institution and public administrative area	0.003	0.997	0.000
X78.1 Residential institution	0.003	0.997	0.000
K82.0 Obstruction of gallbladder	0.000	0.997	0.003
N08.3 Glomerular disorders in diabetes mellitus	0.003	0.997	0.000
N29.8 Other disorders of kidney and ureter in other diseases classified elsewhere	0.003	0.997	0.000
N29.1 Other disorders of kidney and ureter in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
N29.0 Late syphilis of kidney	0.003	0.997	0.000
K61 Abscess of anal and rectal regions	0.003	0.997	0.000
S81.8 Open wound of other parts of lower leg	0.003	0.997	0.000
E12 Malnutrition-related diabetes mellitus	0.003	0.997	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N05.6 Dense deposit disease	0.003	0.997	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N05.0 Minor glomerular abnormality	0.003	0.997	0.000
K65-K67 Diseases of peritoneum	0.003	0.997	0.000
E10.7 With multiple complications	0.003	0.997	0.000
E10.6 With other specified complications	0.003	0.997	0.000
E10.0 With coma	0.003	0.997	0.000
X69.9 Unspecified place	0.003	0.997	0.000
X69.8 Other specified place	0.003	0.997	0.000
X69.7 Farm	0.003	0.997	0.000
X69.6 Industrial and construction area	0.003	0.997	0.000
X69.5 Trade and service area	0.003	0.997	0.000
X69.4 Street and highway	0.003	0.997	0.000
X69.3 Sports and athletics area	0.003	0.997	0.000
X69.2 School, other institution and public administrative area	0.003	0.997	0.000
X69.1 Residential institution	0.003	0.997	0.000
E10.2 With renal complications	0.003	0.997	0.000
N05.9 Unspecified	0.003	0.997	0.000
N05.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
X68.8 Other specified place	0.003	0.997	0.000
X68.7 Farm	0.003	0.997	0.000
X68.6 Industrial and construction area	0.003	0.997	0.000
X68.5 Trade and service area	0.003	0.997	0.000
X68.4 Street and highway	0.003	0.997	0.000
X68.3 Sports and athletics area	0.003	0.997	0.000
X68.2 School, other institution and public administrative area	0.003	0.997	0.000
X68.1 Residential institution	0.003	0.997	0.000
X68.0 Home	0.003	0.997	0.000
X60.8 Other specified place	0.003	0.997	0.000
E11.4 With neurological complications	0.003	0.997	0.000
E13.9 Without complications	0.003	0.997	0.000
E10.8 With unspecified complications	0.003	0.997	0.000
N02.8 Other	0.002	0.997	0.000
X67.8 Other specified place	0.003	0.997	0.000
X67.7 Farm	0.003	0.997	0.000
X67.6 Industrial and construction area	0.003	0.997	0.000
X67.5 Trade and service area	0.003	0.997	0.000
X67.4 Street and highway	0.003	0.997	0.000
X67.3 Sports and athletics area	0.003	0.997	0.000
X67.2 School, other institution and public administrative area	0.003	0.997	0.000
X67.1 Residential institution	0.003	0.997	0.000
X67.0 Home	0.003	0.997	0.000
N25.9 Disorder resulting from impaired renal tubular function, unspecified	0.002	0.997	0.000
N25.1 Nephrogenic diabetes insipidus	0.002	0.997	0.000
N25.0 Renal osteodystrophy	0.002	0.997	0.000
E10.9 Without complications	0.003	0.997	0.000
E10.4 With neurological complications	0.003	0.997	0.000
Z80.0 Family history of malignant neoplasm of digestive organs	0.000	0.997	0.003
S81 Open wound of lower leg	0.003	0.997	0.000
X60.9 Unspecified place	0.002	0.997	0.000
X60.0 Home	0.002	0.997	0.000
X60.7 Farm	0.002	0.997	0.000
X60.6 Industrial and construction area	0.002	0.997	0.000
X60.5 Trade and service area	0.002	0.997	0.000
X60.4 Street and highway	0.002	0.997	0.000
X60.3 Sports and athletics area	0.002	0.997	0.000
X60.2 School, other institution and public administrative area	0.002	0.997	0.000
X60.1 Residential institution	0.002	0.997	0.000
X63.99 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system; Unspecified place ;During unspecified activity	0.002	0.997	0.000
R25.2 Cramp and spasm	0.003	0.997	0.000
F17.9 Unspecified mental and behavioural disorder	0.002	0.997	0.000
F17.8 Other mental and behavioural disorders	0.002	0.997	0.000
F17.7 Residual and late-onset psychotic disorder	0.002	0.997	0.000
F17.6 Amnesic syndrome	0.002	0.997	0.000
F17.5 Psychotic disorder	0.002	0.997	0.000
F17.4 Withdrawal state with delirium	0.002	0.997	0.000
F17.3 Withdrawal state	0.002	0.997	0.000
F17.0 Acute intoxication	0.002	0.997	0.000
K61.4 Intrasphincteric abscess	0.003	0.997	0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.002	0.997	0.000
D32.0 Cerebral meninges	0.003	0.997	0.000
N00.9 Unspecified	0.002	0.997	0.000
N00.8 Other	0.002	0.997	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.002	0.997	0.000
N00.6 Dense deposit disease	0.002	0.997	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.997	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.997	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.997	0.000
N00.2 Diffuse membranous glomerulonephritis	0.002	0.997	0.000
N00.1 Focal and segmental glomerular lesions	0.002	0.997	0.000
N00.0 Minor glomerular abnormality	0.002	0.997	0.000
N01.9 Unspecified	0.002	0.997	0.000
N01.8 Other	0.002	0.997	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.002	0.997	0.000
N01.6 Dense deposit disease	0.002	0.997	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.997	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.997	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.997	0.000
N01.2 Diffuse membranous glomerulonephritis	0.002	0.997	0.000
N01.1 Focal and segmental glomerular lesions	0.002	0.997	0.000
N01.0 Minor glomerular abnormality	0.002	0.997	0.000
N06.9 Unspecified	0.002	0.997	0.000
N06.8 Other	0.002	0.997	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.002	0.997	0.000
N06.6 Dense deposit disease	0.002	0.997	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.997	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.997	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.997	0.000
N06.2 Diffuse membranous glomerulonephritis	0.002	0.997	0.000
N06.1 Focal and segmental glomerular lesions	0.002	0.997	0.000
N06.0 Minor glomerular abnormality	0.002	0.997	0.000
N07.9 Unspecified	0.002	0.997	0.000
N07.8 Other	0.002	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations